Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Target Organ Damage and Blood Pressure, Retinal Vessels, Oxidative Stress and Polymorphisms Vav-2 and Vav-3 in Hypertensive Subjects (LOD-Hypertension)

NCT02022618 is registered in ClinicalTrials.gov with Fundacion para la Investigacion y Formacion en Ciencias de la Salud as lead sponsor.

NCT NCT02022618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02022618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Target Organ Damage and Blood Pressure, Retinal Vessels, Oxidative Stress and Polymorphisms Vav-2 and Vav-3 in Hypertensive Subjects (LOD-Hypertension)
Lead sponsor
Fundacion para la Investigacion y Formacion en Ciencias de la Salud
Phase
Observational
Overall status
Completed
Start date
October 31, 2013
Completion date
March 31, 2016
Enrollment
454 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension